INVEGA
- Product NDC
- 21695-455
- 11-digit product format
- 216950455
- Labeler code
- 21695
- Product ID
- 21695-455_8de6a6eb-9ed8-4e05-9a4c-d657b5634f76
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- paliperidone
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Rebel Distributors Corp
- Application
- NDA021999
- Marketing category
- NDA
- Marketing start
- 2006-12-19
- Marketing end
- 0000-00-00
- Substance
- PALIPERIDONE
- Active strength
- 6 mg/1
- Pharmacologic classes
- Atypical Antipsychotic [EPC]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 21695-455-30 | INVEGA | 30 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 30 | | 1 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| paliperidone | ACTIVE INGREDIENT | 838F01T721 | INVEGA (PALIPERIDONE) TABLET, EXTENDED RELEASE [REBEL DISTRIBUTORS CORP] | 1 | |
| paliperidone | ACTIVE MOIETY | 838F01T721 | INVEGA (PALIPERIDONE) TABLET, EXTENDED RELEASE [REBEL DISTRIBUTORS CORP] | 1 | |
| butylated hydroxytoluene | INACTIVE INGREDIENT | 1P9D0Z171K | INVEGA (PALIPERIDONE) TABLET, EXTENDED RELEASE [REBEL DISTRIBUTORS CORP] | 1 | |
| carnauba wax | INACTIVE INGREDIENT | R12CBM0EIZ | INVEGA (PALIPERIDONE) TABLET, EXTENDED RELEASE [REBEL DISTRIBUTORS CORP] | 1 | |
| cellulose acetate | INACTIVE INGREDIENT | 3J2P07GVB6 | INVEGA (PALIPERIDONE) TABLET, EXTENDED RELEASE [REBEL DISTRIBUTORS CORP] | 1 | |
| ferrosoferric oxide | INACTIVE INGREDIENT | XM0M87F357 | INVEGA (PALIPERIDONE) TABLET, EXTENDED RELEASE [REBEL DISTRIBUTORS CORP] | 1 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | INVEGA (PALIPERIDONE) TABLET, EXTENDED RELEASE [REBEL DISTRIBUTORS CORP] | 1 | |
| polyethylene glycol | INACTIVE INGREDIENT | 3WJQ0SDW1A | INVEGA (PALIPERIDONE) TABLET, EXTENDED RELEASE [REBEL DISTRIBUTORS CORP] | 1 | |
| povidone | INACTIVE INGREDIENT | FZ989GH94E | INVEGA (PALIPERIDONE) TABLET, EXTENDED RELEASE [REBEL DISTRIBUTORS CORP] | 1 | |
| propylene glycol | INACTIVE INGREDIENT | 6DC9Q167V3 | INVEGA (PALIPERIDONE) TABLET, EXTENDED RELEASE [REBEL DISTRIBUTORS CORP] | 1 | |
| sodium chloride | INACTIVE INGREDIENT | 451W47IQ8X | INVEGA (PALIPERIDONE) TABLET, EXTENDED RELEASE [REBEL DISTRIBUTORS CORP] | 1 | |
| stearic acid | INACTIVE INGREDIENT | 4ELV7Z65AP | INVEGA (PALIPERIDONE) TABLET, EXTENDED RELEASE [REBEL DISTRIBUTORS CORP] | 1 | |
| titanium dioxide | INACTIVE INGREDIENT | 15FIX9V2JP | INVEGA (PALIPERIDONE) TABLET, EXTENDED RELEASE [REBEL DISTRIBUTORS CORP] | 1 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 21695-455 | INVEGA (PALIPERIDONE) TABLET, EXTENDED RELEASE [REBEL DISTRIBUTORS CORP] | 1 | Legacy NDC, 1 package rows | 20110104_8de6a6eb-9ed8-4e05-9a4c-d657b5634f76.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 21695-455-30 | 21695045530 | 30 in 1 BOTTLE | Historical |